BOSTON SCIENTIFIC CORP BSX
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1992-05-19
BOSTON SCIENTIFIC CORP statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 69.0% | 68.6% | 69.5% | 68.8% | 68.8% |
| Operating margin | 18.0% | 15.5% | 16.5% | 13.0% | 10.1% |
| FCF margin | 18.2% | 15.8% | 12.6% | 7.4% | 11.1% |
| Current ratio | 1.62 | 1.08 | 1.32 | 1.51 | 1.48 |
| Revenue growth | 19.9% | 17.6% | 12.3% | 6.7% | 19.9% |
Source: SEC EDGAR filings · CIK 0000885725 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.